Asymmetry Capital Management is a San Francisco-based alternative asset management firm.
Business Model:
Revenue: $4M
Employees: 11-50
Address: One Sansome Street,
City: San Francisco
State: CA
Zip: 94104
Country: US
Asymmetry Capital Management, L.P. is a San Francisco-based alternative asset management firm founded in 2012 by Scott Kay, a 20-year veteran of health care investing. We utilize a data-driven primary research process to identify and invest in out-of-consensus health care companies that we believe have both asymmetric return profiles and near-term valuation catalysts. Our differentiated investment process and focus on fundamental shorts seek to produce a return stream for investors that is both unique and repeatable over the long term. Asymmetry seeks to deliver high risk-adjusted returns, low correlations to both broad market and healthcare indices, and lower volatility.
Contact Phone:
+14158014600
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | MoonLake Immunotherapeutics | Post-IPO Equity | 115M |
8/2021 | Dice Therapeutics | Series C | 60M |
9/2020 | Galecto | Series D | 0 |
1/2021 | Dice Therapeutics | Series C | 80M |
4/2022 | MoonLake Immunotherapeutics | Post-IPO Equity | 0 |
8/2021 | Dice Therapeutics | Series C | 0 |
1/2021 | Dice Therapeutics | Series C | 0 |
9/2020 | Galecto | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|